Lantheus Holdings Inc. Common Stock (LNTH)

FairStock Score: 62/100 — STEADY

Key Financials

Strengths

• Generates $266 million in annual free cash flow (4.9% yield on market cap)
• Strong Piotroski F-Score of 8/9 indicating robust financial health across profitability, leverage, and efficiency metrics
• High return on equity of 21.4% demonstrating efficient capital deployment

Concerns

• Trades significantly above Graham Number ($36) with negative 129% margin of safety—limited downside protection

AI Analysis

Lantheus Holdings Inc. Common Stock is a small-cap healthcare company valued at $5.4 billion. The business generates $1.5 billion in annual revenue with a 3.5% net margin and $266 million in free cash flow. From a quality standpoint, Lantheus shows near-perfect Piotroski F-Score of 8/9 indicating exceptional financial health and healthy Altman Z-Score of 3.9. On valuation, the stock is reasonably priced at 24.3x earnings, with trades far above its Graham Number ($36) with no margin of safety. Growth dynamics show revenue growing at 4.0% and profit growth of 558.8%. Our composite FairStock Score of 62/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $266 million in annual free cash flow (4.9% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer